|
|
||||||||




* Blood Research Institute, The Blood Center of Southeastern Wisconsin, Milwaukee, WI 53226; and
Department of Pediatrics, University at Buffalo-State University of New York, Buffalo, NY 14214;
San Raffaele Telethon Institute for Gene Therapy, Milan, Italy
Active suppression mediated by CD4+CD25+ T regulatory (Tr) cells plays an important role in the down-regulation of T cell responses to both foreign and self-Ags. Platelet factor 4 (PF4), a platelet-derived CXC chemokine, has been shown to strongly inhibit T cell proliferation as well as IFN-
and IL-2 release by isolated T cells. In this report we show that human PF4 stimulates proliferation of the naturally anergic human CD4+CD25+ Tr cells while inhibiting proliferation of CD4+CD25 T cells. In coculture experiments we found that CD4+CD25+ Tr cells exposed to PF4 lose the ability to inhibit the proliferative response of CD4+CD25 T cells. Our findings suggest that human PF4, by inducing Tr cell proliferation while impairing Tr cell function, may play a previously unrecognized role in the regulation of human immune responses. Because platelets are the sole source of PF4 in the circulation, these findings may be relevant to the pathogenesis of certain immune-mediated disorders associated with platelet activation, such as heparin-induced thrombocytopenia and autoimmune thrombocytopenic purpura.
This article has been cited by other articles:
![]() |
Z. Xiao, G. P. Visentin, K. M. Dayananda, and S. Neelamegham Immune complexes formed following the binding of anti-platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion Blood, August 15, 2008; 112(4): 1091 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Li Platelet-lymphocyte cross-talk J. Leukoc. Biol., May 1, 2008; 83(5): 1069 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mueller, A. Meiser, E. M. McDonagh, J. M. Fox, S. J. Petit, G. Xanthou, T. J. Williams, and J. E. Pease CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3 J. Leukoc. Biol., April 1, 2008; 83(4): 875 - 882. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Woller, E. Brandt, J. Mittelstadt, C. Rybakowski, and F. Petersen Platelet factor 4/CXCL4-stimulated human monocytes induce apoptosis in endothelial cells by the release of oxygen radicals J. Leukoc. Biol., April 1, 2008; 83(4): 936 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lasagni, R. Grepin, B. Mazzinghi, E. Lazzeri, C. Meini, C. Sagrinati, F. Liotta, F. Frosali, E. Ronconi, N. Alain-Courtois, et al. PF-4/CXCL4 and CXCL4L1 exhibit distinct subcellular localization and a differentially regulated mechanism of secretion Blood, May 15, 2007; 109(10): 4127 - 4134. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Alving Heparin-induced thrombocytopenia: the female factor Blood, November 1, 2006; 108(9): 2884 - 2885. [Full Text] [PDF] |
||||
![]() |
C. Liu, Q.-H. Sun, and G. P. Visentin The CXC Chemokine Platelet Factor 4 (PF4; CXCL4) Binds to the Neuropilin-1 (NRP1) Receptor Expressed on CD4+CD25+ Regulatory T Cells. Blood (ASH Annual Meeting Abstracts), November 16, 2005; 106(11): 3307 - 3307. [Abstract] |
||||
![]() |
C. Liu, Q.-H. Sun, and G. P. Visentin Global Gene Expression Profiles of Activated CD4+CD25high (Regulatory) and CD4+CD25- (Non-Regulatory) T Cells. Blood (ASH Annual Meeting Abstracts), November 16, 2005; 106(11): 3308 - 3308. [Abstract] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |